Accretive Health Announces Third Quarter 2012 Financial Results Conference Call

Mon Oct 8, 2012 7:30am EDT

* Reuters is not responsible for the content in this press release.

Accretive Health Announces Third Quarter 2012 Financial Results Conference Call

Company to hold conference call and webcast

Accretive Health, Inc. (NYSE: AH) (the “Company”), a leading provider of services to healthcare providers announced that the Company will hold a conference call for investors on Wednesday, November 7, 2012, at 7:30 am central time. During the conference call, management will review highlights from the Company’s third quarter and year to date 2012 results, which will be announced via press release one hour prior to the call, and will discuss the Company’s operations and business outlook.

To participate in the Company’s live conference call and webcast, please dial 800-215-2410 (617-597-5410 for international calls) using conference code No. 22641868, or visit the Investor Relations section of the Company’s web site: www.accretivehealth.com. A replay will be available for one week following the conference call at 888-286-8010 (617-801-6888 for international calls) using conference code No. 84883235. A webcast replay will also be archived on Accretive Health’s investor relations website at http://ir.accretivehealth.com in the “Webcasts and Presentations” section.

About Accretive Health

Accretive Health partners with healthcare providers to help them more effectively manage their revenue cycles, strengthen their financial stability, and improve the quality of care they provide while reducing overall healthcare costs. Our people, processes and sophisticated integrated technology complement our clients' existing resources to enhance results for patients, physicians and staff. For more information, please visit www.accretivehealth.com.

Accretive Health, Inc.
Gary Rubin, 312-324-7813
Senior Director - Investor Relations Officer
investorrelations@accretivehealth.com

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.